Patent ID: 7858616
Filing Date: 2010-12-28
Classification: A61P,C07D

Abstract:
1. A method for treating excessive or abnormal endothelial cell proliferation comprising administering a compound of the formula in which X is an oxygen atom, R R R R where all dialkylamino groups present in the radical R R R where the abovementioned alkyl groups include linear and branched alkyl groups in which additionally one to 3 hydrogen atoms may be replaced by fluorine atoms, where additionally a carboxyl, amino or imino group present may be substituted by an in vivo cleavable radical or may be present in the form of a prodrug radical, for example in the form of a group which can be converted in vivo into a carboxyl group or in the form of a group which can be converted in vivo into an imino or amino group, or a salt thereof.